期刊文献+

米多君与特利加压素对肝硬化腹水患者血流动力学影响效果比较的临床观察 被引量:9

原文传递
导出
摘要 肝硬化腹水是肝硬化失代偿期最突出的临床表现之一,其发病机制复杂,包括门脉高压、血浆胶体渗透压降低、肝淋巴液形成增多等。重视肝硬化腹水的规范化治疗,对于延长肝硬化患者生命,提高生活质量具有重要的意义。
作者 肖丹 程波
出处 《临床内科杂志》 CAS 2016年第7期467-468,共2页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献9

  • 1刘成海,姚树坤.肝硬化腹水的中西医结合诊疗共识意见[J].中国中西医结合杂志,2011,31(9):1171-1174. 被引量:230
  • 2谢渭芬.重视肝硬化腹水的规范化治疗[J].中华消化杂志,2013,33(9):577-580. 被引量:8
  • 3王文虎,王鲁文,龚作炯.肝硬化腹水患者低钠血症与病情严重程度的关系[J].临床内科杂志,2007,24(9):636-637. 被引量:5
  • 4Mohammad M, Leila F, Mehdi R, et al. Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites [ J ]. J Res Med Sci,2011,16 ( 1 ) : 87-93.
  • 5Schrier RW, Arroyo V, Bemardi M, et al. Peripheral arterial vasodilatian hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis [ J ]. Hepatology, 1988,8 (5) : 1151-1157.
  • 6田秋菊,贾继东.肝硬化腹水及其相关并发症治疗新进展[J].实用肝脏病杂志,2015,18(1):1-3. 被引量:39
  • 7Tsuchida K, Yamazaki R, Kaneko K, et al. Effects of midodrine on blood flow in dog vascular beds [ J ]. Arzneimittelforschung, 1986,36 ( 12 ) : 1745 -1748.
  • 8Kalambokis G,Economou M, Fotopoulos A, et al. The effects of chronic treatment with octreotide versus oetreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function innonazotemie cirrhotic patients with aseites[J].Am J Gastroenterol, 2005,100 (4) : 879-885.
  • 9Singh V, Dhungana SP, Singh B, et al. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study [J]. J Hepatol,2012,56(2):348-354.

二级参考文献13

  • 1危北海,张万岱,陈治水,张育轩.肝硬化中西医结合诊治方案(草案)[J].中国中西医结合杂志,2004,24(10):869-871. 被引量:215
  • 2肝硬化临床诊断、中医辨证和疗效评定标准(试行方案)[J].中国中西医结合杂志,1994,14(4):237-238. 被引量:347
  • 3Runyon BA. AASLD practice guideline: management of a- dult patients with ascites due to cirrhosis: an update [ J ]. Hepatology, 2009, 49 (6) : 2087 - 2107.
  • 4王永炎.中医内科学[M].上海:上海科学技术出版社,2002.124-132.
  • 5Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the international ascites club.Hepatology,2003,8:258 -266.
  • 6Ferenci P,Lockwood AH,Mullen KD,et al.Hepatic encephalopathy definition,nomenclature,diagnosis,and quantification:final report of the working party at the 11 th World Congress of Gastroenterology,Vienna,1998.Hepatology,2002,35:716-721.
  • 7Gine's P,Berl T,Bernardi M,et al.Hyponatremia in cirrhosis:from pathogenesis to treatment.Hepatology,1998,8:851-864.
  • 8Malinchoc M,Kamath PS,Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunt.Hepatology,2000,31:864-871.
  • 9Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease.Hepatology,2001,33:464-470.
  • 10Haussinger D.Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.Hepatology,2006,43:1187-1190.

共引文献276

同被引文献66

引证文献9

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部